BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 4413891)

  • 1. Inhibition of gastric acid secretion and ulcer formation in the rat by orally-administered 11-deoxyprostaglandin analogues: 15-hydroxy-16,16-dimethyl-9-oxoprost-5,13-dienoic acids.
    Lippmann W
    Prostaglandins; 1974 Aug; 7(3):231-46. PubMed ID: 4413891
    [No Abstract]   [Full Text] [Related]  

  • 2. Oral gastric acid secretion-inhibitory activity and anti-ulcer activity of synthetic prostaglandin analogues: C-15 epimers of 15-hydroxy-15-methyl-9-oxoprostanoic acid (AY-22,469).
    Lippmann W
    Prostaglandins; 1974 Aug; 7(3):223-9. PubMed ID: 4414938
    [No Abstract]   [Full Text] [Related]  

  • 3. Inhibition of gastric acid secretion in the rat by synthetic prostaglandin analogues.
    Lippmann W
    Ann N Y Acad Sci; 1971 Apr; 180():332-5. PubMed ID: 5286101
    [No Abstract]   [Full Text] [Related]  

  • 4. The effect of locally administered prostaglandin 15 (R) 15 methyl-E2 methyl ester on gastric ulcer formation in the Shay rat preparation.
    Carter DC; Ganesan PA; Bhana D; Karim SM
    Prostaglandins; 1974 Mar; 5(5):455-62. PubMed ID: 4822194
    [No Abstract]   [Full Text] [Related]  

  • 5. Inhibition of gastric acid secretion in the rat by orally-administered synthetic prostaglandin analogues: enantiomorphs of 15-hydroxy-15-methyl-9-oxoprostanoic acid.
    Lippmann W
    J Pharm Pharmacol; 1974 Oct; 26(10):831-3. PubMed ID: 4156547
    [No Abstract]   [Full Text] [Related]  

  • 6. Effect of orally administered prostaglandin E 2 and its 15-methyl analogues on gastric secretion.
    Karim SM; Carter DC; Bhana D; Ganesan PA
    Br Med J; 1973 Jan; 1(5846):143-6. PubMed ID: 4706806
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Gastric antisecretory and antiulcer properties of PGE2, 15-methyl PGE2, and 16, 16-dimethyl PGE2. Intravenous, oral and intrajejunal administration.
    Robert A; Schultz JR; Nezamis JE; Lancaster C
    Gastroenterology; 1976 Mar; 70(3):359-70. PubMed ID: 174967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pathogenesis of peptic ulcer.
    Ivey KJ
    Aust N Z J Med; 1974 Feb; 4(1):71-4. PubMed ID: 4367503
    [No Abstract]   [Full Text] [Related]  

  • 9. Relationship between the prevention of rat gastric erosions and the inhibition of acid secretion by prostaglandins.
    Whittle BJ
    Eur J Pharmacol; 1976 Dec; 40(2):233-9. PubMed ID: 11107
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sympathomimetic amines and gastric secretion in rats.
    Fjalland B
    Acta Pharmacol Toxicol (Copenh); 1974 Oct; 35(4):293-9. PubMed ID: 4479360
    [No Abstract]   [Full Text] [Related]  

  • 11. Effect of prostaglandin E1 on gastric secretion and ulcer formation in the rat.
    Robert A; Nezamis JE; Phillips JP
    Gastroenterology; 1968 Oct; 55(4):481-7. PubMed ID: 5698627
    [No Abstract]   [Full Text] [Related]  

  • 12. Inhibition of indomethacin-induced gastric ulceration in the rat by perorally-administered synthetic and natural prostaglandin analogues.
    Lippmann W
    Prostaglandins; 1974 Jul; 7(1):1-10. PubMed ID: 4852476
    [No Abstract]   [Full Text] [Related]  

  • 13. Effects of prostaglandins on the stomach and the intestine.
    Robert A
    Prostaglandins; 1974 Jun; 6(6):523-32. PubMed ID: 4366018
    [No Abstract]   [Full Text] [Related]  

  • 14. Oral antigastric acid secretory activity of synthetic prostaglandin analogues (9-oxoprostanoic acids).
    Lippmann W
    Experientia; 1973 Aug; 29(8):990-1. PubMed ID: 4733330
    [No Abstract]   [Full Text] [Related]  

  • 15. Indomethacin. Effect on gastric secretion, parietal cell population, and ulcer provocation in the dog.
    Nicoloff DM
    Arch Surg; 1968 Nov; 97(5):809-15. PubMed ID: 5684598
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of oral administration of PGE2 on gastric secretion and experimental peptic ulcerations.
    Lee YH; Cheng WD; Bianchi RG; Mollison K; Hansen J
    Prostaglandins; 1973 Jan; 3(1):29-45. PubMed ID: 4571459
    [No Abstract]   [Full Text] [Related]  

  • 17. Actions of prostacyclin (PGI2) and its product, 6-oxo-PGF1alpha on the rat gastric mucosa in vivo and in vitro.
    Whittle BJ; Boughton-Smith NK; Moncada S; Vane JR
    Prostaglandins; 1978 Jun; 15(6):955-67. PubMed ID: 358297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of human gastric secretion by prostaglandin.
    Carter DC; Karim SM; Bhana D; Ganesan PA
    Br J Surg; 1973 Oct; 60(10):828-31. PubMed ID: 4748390
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostaglandins: therapy for peptic ulcer?
    Wilson DE
    Ann Intern Med; 1973 Aug; 79(2):269-70. PubMed ID: 4580114
    [No Abstract]   [Full Text] [Related]  

  • 20. The effects E and A prostaglandins on gastric mucosal blood flow and acid secretion in the rat.
    Main IH; Whittle BJ
    Br J Pharmacol; 1973 Nov; 49(3):428-36. PubMed ID: 4149696
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.